Tags » Announces

Prollenium Medical Technologies Inc. announces U.S. FDA approval for its cross-linked hyaluronic


AURORA, ON, Aug. 17, 2017 /PRNewswire/ Prollenium Medical Technologies Inc., a leading medical device manufacturer, announced today its United States (U.S.) Food and Drug Administration (FDA) approval for its cross-linked hyaluronic acid dermal filler. 42 more words

Peabody Announces That The Secondary Offering By Certain Selling Stockholders Has Been Priced


The selling stockholders will receive all of the net proceeds from the offering. Peabody is not offering any shares of common stock in the offering and will not receive any proceeds from the sale of shares in the offering. 42 more words

HempLife Today Announces its new Website will be live by 5PM EDT on Friday, 8.18.2017

Who have learned that Hemp, and Hemp related products, can be a great source of increased health, vitality, and overall well being in our lives. Cannabidiol (CBD) is a non-psychoactive cannabiniod compound found in industrial hemp and cannabis. 8 more words

News & Features

Peabody Announces Launch Of Secondary Offering By Certain Selling Stockholders, Repurchase Of


The selling stockholders will receive all of the net proceeds from the offering. Peabody is not offering any shares of common stock in the offering and will not receive any proceeds from the sale of shares in the offering. 40 more words

Nielsen announces new division unit to measure e-sports sponsorships

(Source: techcrunch.com)

Another sign that e-sports are turning into a big business: Nielsen is launching a new division focused providing research and consulting to the industry. 249 more words

Technology

SCTA Announces 2017 League Captain Of The Year Program


USTA Southern California Announces 2017 League Captain Of The Year Program The USTA Southern California has announced a Section-wide Captain Appreciation and Recognition program. For each league division (Adult 18… Read more… 6 more words

News & Features

SillaJen Announces Collaboration with the National Cancer Institute for Development of Combination


We welcome the opportunity to collaborate with Dr. Greten in the development of this promising combination therapy, said Eun Sang Moon, chief executive officer of SillaJen. 53 more words